UC Medical Center Recertified as Advanced Stroke Care Center
University of Cincinnati (UC) Medical Center has again earned The Joint Commissions Advanced Certification for Comprehensive Stroke Centers, the highest level of certification reserved for institutions with specific abilities to receive and treat the most complex stroke cases.
- The UC Stroke Team, founded as the first multidisciplinary stroke team in the U.S. during the mid-1980s, provides stroke evaluation for acute stroke therapy around the clock at 15 regional hospitals, as well as consultation at over 20 other regional hospitals.
- In 2012, the UC Gardner Neuroscience Institute and UC Medical Center launched a major initiative to bring the expertise of the UC Stroke Team to partner hospitals through telestroke, the use of telemedicine specifically for stroke care.
- UC researchers played a leading role in developing and testing the clot-busting drug tissue plasminogen activator, or tPA, to treat acute ischemic stroke. Such a stroke occurs when an artery to the brain is blocked, typically by a blood clot. Intravenous tPA is the only FDA-approved medical treatment for stroke caused by a blood clot.
- UC is the National Coordinating Center for the NIH-funded StrokeNet, a network of major research hospitals across the country conducting state-of-the-art stroke research in prevention, treatment and recovery.
- UC researchers also direct neurorecovery/neuroimaging studies in stroke recovery, participate in the major medical and surgical prevention studies and have an active translational laboratory studying preclinical models of stroke and cerebrovascular disease.
Related Stories
UC students organize free health clinic in community
July 15, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
University of Cincinnati advances FLASH radiation therapy with new clinical trial
July 15, 2026
UC Cancer Center researchers led the FAST-02 trial, showing ultra-high-dose-rate FLASH proton therapy near the heart and lungs safely reduced pain from thoracic bone metastases.
New UC Center for Alzheimer's and Neurodegenerative Diseases Research to advance dementia research, treatment and education
July 14, 2026
The University of Cincinnati and UC Health are launching the Center for Alzheimer's and Neurodegenerative Diseases Research (CANDR) to advance dementia research, clinical care and brain health education.